CD274 and small cell lung carcinoma: For small cell lung cancer (SCLC), a cationic liposome co-delivering paclitaxel and PFKFB4-targeting siRNA induces ferroptosis, reprograms the immunosuppressive microenvironment, and enhances PD-L1 blockade efficacy (74–76).